Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables

Value{"unit": "CHF", "value": -59446}
Period2021-01-01 – 2021-06-30
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-21-046965
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/8fc9c217-b923-4303-9d7c-361be0bea10a

History